Archives: Speakers

John combines more than 20 years experience in clinical data management, PCOR science and clinical trial operations with expertise leading the development of data pipelines, knowledge management products and new processes to advance the use of eCOA & digital measures in clinical trials.

John is an expert in the execution and scaling of patient and site facing clinical trial technologies who gained a BSc in Biology from the University of Bristol in the UK. Before joining DEEP John worked for Roche for over 9 years where he led external industry collaborations and played a leadership role in the co-creation of a new operational framework and ecosystem of data/ technology products to support the digital health technology lifecycle.

John now works for DEEP as a Science Liaison where he partners closely with DEEP’s existing customers, helping them to maximize value gain through collaboration.

Chemical engineer, with over 8 years of experience in laboratory and R&D activities, including laboratory management and quality control at brewing industry. Sales manager at ColloidTek.

Tajuana Barron is the Vice President of Project Management responsible for project delivery. Ms. Barron joined PCM Trials in 2022 with over 30 years of clinical research experience working for Pharma companies and CROs.

Prior to joining PCM Trials, Ms. Barron served as a Senior Director of Project Management at PPD, where her responsibilities included oversight of a strategic partnership, DCT strategy and management of a team of project directors and managers. Previously, she held leadership roles at PRA and Schering Plough Research Institute. Ms. Barron earned a Bachelor of Science in Chemistry from Bennett College and studied at the University of Medicine & Dentistry of New Jersey.

Martin Czakon, MSc, brings extensive clinical research and business development expertise to his role as EMEA Head of Commercial Strategy & Growth at Care Access. With over 12 years in executive roles within global CRO providers and patient enrollment organizations, Martin excels in strategical planning, leadership, and patient recruitment, maximizing study efficiency.

As Therapeutic Area Head at Julius Clinical and former Senior Business Development Director at Bioclinica, Martin leveraged executive experience to position companies as industry leaders. With a background as a former board-certified physiotherapist, he offers a unique perspective on clinical research challenges. Martin excels in developing relationships and navigating complexities in CRO service offerings, driving successful outcomes.

Ellen Weiss connects CROs and sponsors with right-sized hybrid and remote solutions. She has spoken on the logistical support necessary for IMP delivery and dosing, sample collection, and the services provided by clinical trial research nurses that enable alternate-site visits to be carried out with the same data quality and subject safety as on-site visits. Ellen is a member of the Healthcare Businesswomen’s Association and is a volunteer for the American Society of Clinical Oncology.

Tajuana Barron is the Vice President of Project Management responsible for project delivery. Ms. Barron joined PCM Trials in 2022 with over 30 years of clinical research experience working for Pharma companies and CROs.

Prior to joining PCM Trials, Ms. Barron served as a Senior Director of Project Management at PPD, where her responsibilities included oversight of a strategic partnership, DCT strategy and management of a team of project directors and managers. Previously, she held leadership roles at PRA and Schering Plough Research Institute. Ms. Barron earned a Bachelor of Science in Chemistry from Bennett College and studied at the University of Medicine & Dentistry of New Jersey.

Amber Hill, PhD, is a distinguished figure in the intersection of research, global community engagement, and AI technology. She is the founder and CEO of Research Grid (R.grid), a pioneering AI tech company that has developed an automation engine for admin-free clinical trials. Dr. Hill holds a PhD in Biomedical Neuroscience from University College London (UCL), where she also completed a postdoctoral fellowship focusing on widening access to research through AI, supplemented by a stint in Computer Science at Harvard University. Additionally, she has enhanced her leadership skills through a management program at MIT Sloan.

During her time as a student, Dr. Hill founded the nonprofit Movement for Hope, which engages in cross-disciplinary initiatives globally to raise awareness for neurological conditions and broaden access to research. At Research Grid, Dr. Hill leads the development of two innovation products -Inclusive and TrialEngine – which automates back-office tasks for engagement and clinical trials, respectively, streamlining processes to enhance efficiency and accessibility in medical research.